Health & Fitness
Health and Fitness
Health and Fitness
Mon, August 30, 2010Sun, August 29, 2010Fri, August 27, 2010Thu, August 26, 2010Wed, August 25, 2010Tue, August 24, 2010Mon, August 23, 2010Fri, August 20, 2010Thu, August 19, 2010Wed, August 18, 2010Tue, August 17, 2010Mon, August 16, 2010Fri, August 13, 2010Thu, August 12, 2010Wed, August 11, 2010Tue, August 10, 2010Mon, August 9, 2010Fri, August 6, 2010Thu, August 5, 2010Wed, August 4, 2010Tue, August 3, 2010Ryan & Maniskas, LLP Announces Investigation of Trubion Pharmaceuticals, Inc.
Published in Health and Fitness on Friday, August 13th 2010 at 13:30 GMT by Market Wire
WAYNE, Pa.--([ BUSINESS WIRE ])--Ryan & Maniskas, LLP ([ www.rmclasslaw.com/cases/trbn ]) is investigating potential claims against the board of directors of Trubion Pharmaceuticals, Inc. ("Trubion" or the "Company") (NASDAQ:TRBN) concerning possible breaches of fiduciary duty and other violations of law related to the Companya™s entry into an agreement to be acquired by Emergent BioSolutions Inc. (aEmergenta) in a transaction valued at approximately $96.8 million.
Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Companya™s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of Trubion. For more information regarding our investigation, please contact Ryan & Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or by email at [ rmaniskas@rmclasslaw.com ] or visit: [ www.rmclasslaw.com/cases/trbn ].
Under the proposed agreement, each share of Trubion common stock will be converted into the right to receive $1.365 per share in cash and 0.1641 shares of Emergent stock. In addition, Trubion shareholders will receive one contingent value right ("CVR") per share, which will entitle the holder to receive cash payments based upon the achievement of certain milestones. The total potential aggregate value of the CVRs is $38.7 million over a three year period.
If you own shares of Trubion and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: [ www.rmclasslaw.com/cases/trbn ]. You may also email Mr. Maniskas at [ rmaniskas@rmclasslaw.com ]. For more information about class action cases in general, please visit our website: [ www.rmclasslaw.com ].
Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan and Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
